Abstract
A new angle on sudden cardiac death suggests that thrombosis may play a part in this post-MI phenomenon, indicating a possible new role for thrombolytic drugs. Meanwhile, the quest for more effective thrombolytic strategies for acute myocardial infarction continues, with studies of reteplase and low-dose combination regimens showing encouraging results. However, according to the findings of a provocative study, high-dose heparin alone may be an effective alternative to thrombolytic agents. Details of these approaches to treatment, along with new findings for adjunctive therapy in thrombolysis, were presented at the 67th Scientific Sessions of the American Heart Association [ Dallas, US; November 1994 ].
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
